Vanguard Global Advisers »

Adaptive Biotechnologies Cor shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Adaptive Biotechnologies Cor (ADPT) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Adaptive Biotechnologies Cor

Tip: Access up to 7 years of quarterly data

All positions including Adaptive Biotechnologies Cor held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptive Biotechnologies Cor by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $891k 64k 13.88

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Adaptive Biotechnologies Cor

Viking Global Investors
BlackRock
Vanguard Group
Vanguard Capital Management
Westfield Capital Management Company
Vanguard Portfolio Management
Invesco
Geode Capital Management
Lord, Abbett & Co
Goldman Sachs Group
State Street Corporation
Ameriprise Financial
Driehaus Capital Management
Arrowstreet Capital, Limited Partnership
Wellington Management Company

View all funds holding Adaptive Biotechnologies Cor